Abstract. We report on a female patient with severe infantile spasms, profound global developmental arrest, hypsarrhythmia and severe mental retardation, associated with a de novo apparently balanced X;autosome translocation. Her neurological phenotype resembles that of X-linked infantile spasms (ISSX). Molecular study showed that the translocation disrupts a transcript involved in GTPases signalling, IQSEC2, mapped to the Xp11.22 region. Several genes involved in intracellular signalling pathways via Ras-homologous small GTPase have been implicated in X-linked neurological disorders. Expression studies revealed that the murine homolog of this transcript, Iqsec2, is highly expressed in the nervous system from the early stages of development. These data suggest that IQSEC2 could be considered a candidate gene for X-linked neurological disorders.
Introduction
Infantile spasm syndrome (ISS), also called West syndrome, is an etiologically heterogenous disorder with an incidence of 2-5 per 10,000 live births. It is characterized by seizures that usually start early in life with an electroencephalogram pattern of hypsarrhythmia and subsequent mental retardation. Most cases are sporadic, but familial cases have been reported as an isolated finding or in association with a variety of abnormalities. An X-linked form of West syndrome has been reported (ISSX, MIM 308350) and some of these patients have been shown to carry mutations in the ARX (aristaless-related homeobox) gene, which maps to Xp21.3-p22.1 (1) . ARX was also found mutated in patients with mental retardation, lissencephaly and abnormal genitalia (2) . Recently a second gene, CDKL5 (cyclin-dependent kinase-like 5), which maps to Xp22.3, was found mutated in patients with X-linked infantile spasms (ISSX) and in patients with the early seizure variant of Rett syndrome (RTT; reviewed in ref. 3) . RTT (MIM 312750), an X-linked dominant male lethal neurodevelopmental disorder caused by a mutation in the MECP2 gene and characterized by a wide spectrum of clinical manifestations, was also found to be associated with West syndrome (4) . Mutation analysis suggests the existence of additional loci possibly involved in both ISS and RTT (3, (5) (6) (7) (8) (9) .
Here, we report on a female patient, named AD, with a phenotype resembling ISSX. Chromosome analysis showed a de novo apparently balanced X;autosome translocation involving the short arm of the X chromosome and the long arm of chromosome 20. FISH analysis allowed us to map the X chromosome breakpoint inside the first intron of the IQSEC2 transcript in the Xp11.22 region. Expression studies revealed that the Iqsec2 murine homolog is highly expressed in the central and peripheral nervous systems.
These results led us to hypothesise that the phenotype observed in the patient could be the result of a disruption of the IQSEC2 gene in Xp11.22, thus rendering IQSEC2 a candidate gene for ISSX and RTT-like cases characterized by the early onset of seizures and other neurological phenotypes.
Materials and methods
In silico analysis. BAC contigs necessary for the characterization of the patient's breakpoints were established in silico using the UCSC Genome Bioinformatics web site (http:// genome.ucsc.edu/cgi-bin/hgGateway). (FISH) . BAC clones used for FISH studies were derived from the RPCI-11 Human Male BAC Library (10) . FISH analysis was performed on chromosome metaphases of fibroblastoid cell line of the patient. FISH studies were performed as described (11) .
Fluorescence in situ hybridisation
X chromosome inactivation studies. Primers were designed in the (CAG)n flanking sequences of the androgen receptor (HUMARA) gene intron 1 (12) . Forward primer AR-P1 was labelled (Fam) and the reverse primer was unlabelled. Primer sequences were: AR-P1: Fam 5'TCC AGA ATC TGT TCC AGA GCG TGC 3'; AR-P2: 5'GCT GTG AAG GTT GCT GTT CCT CAT3'. A total of 800 ng of DNA was digested by HpaII and ethanol precipitated. PCR reactions were performed with 100 ng of DNA on both HpaII digested and undigested DNA from the mother and the daughter. PCR conditions were as follows: 1X PCR buffer, 0.2 mmol/l dNTP, 1.25 mmol/l Mg ++ and 0.5 U AmpliTaq Gold (Applied Biosystems), in a 20-μl final volume. Annealing temperature was 60˚C for 28 cycles. PCR products were electrophoresed on an ABI PRISM 3100 Genetic Analyzer, and peak heights were analyzed using GeneScan software (Applied Biosystem). Table I . Primer sequences used in the study.
Forward primer Reverse primer Ta (˚C)  PCR product  length (bp)  -----------------------------------------------------------------------------------------------------IQSEC2  1  tcctcccgagcagtggctg  ctctcgatgatgttgttcagctcc  60  333  ggatccgagagcccaa 
RNA in situ hybridization. The expression pattern of Iqsec2 was examined by RNA in situ hybridization on murine sections from E14.5 and E16.5, and adult brain. Two different riboprobes were used. One, corresponding to a 826-bp sequence spanning exons 4-5 of Iqsec2, was transcribed from the cDNA clone IMAGE:803296 (acc. AA396309). The second was obtained by PCR amplification of the cDNA clone IMAGE:6530479 (acc. BU523772) and is specific for the 1010-bp sequence of the 3'UTR of IQSEC2 (primer sequences available upon request). RNA in situ hybridization experiments were performed as described (13) .
Mutation screening. For mutation analysis of the MECP2 and CDKL5 genes, primers and conditions were as described (8, 14) . In order to perform mutation analysis for ARX and IQSEC2, primers were designed to amplify exons and exonintron boundaries. The boundaries were determined by the alignment of the consensus cDNA sequences with available genomic sequences. PCRs were carried out on genomic DNA extracted from peripheral blood leukocytes. Mutation analysis was performed by denaturing high performance liquid chromatography using the Wave DNA fragment analysis system (Transgenomic, Inc.) according to the manufacturer's instructions. Table I shows the primer sequences, PCR product length and annealing temperatures. Full ethical approval was obtained for the study.
Results
Case report. AD was the second female child born to unrelated parents. She was born by induced vaginal delivery at 37 weeks gestation following an uncomplicated pregnancy. Delivery was induced for premature rupture of membranes. She was born with a left talipes equinovarus, treated with casting and later surgery, and congenital hip dislocation, which was corrected with a Pavlik harness. She was also noted to have esotropia requiring surgical correction. Development was apparently normal for the first 6-8 months, but subsequently slowed and regressed. She did not sit until 13 months of age, and never learned to crawl or walk. She said 'mama' and 'papa' at 12-13 months of age. At 15 months, she developed severe myoclonic seizures involving both arms, which have been refractory to therapy. Since the development of the seizures she has not gained any new skills, has stopped speaking and has regressed to babbling again. She cannot eat solid foods and has remained on liquids.
She is severely hypotonic, with full range of motion in all extremities. Her growth, regarding weight and height, and head circumference have been normal. Her features are not dysmorphic. Her EEG was consistent with hypsarrhythmia and a brain MRI showed non-specific volume loss and periventricular white matter changes, but no structural brain abnormalities. She is now 12 years old. Chromosome analysis showed a de novo apparently balanced translocation 46,X, t(X;20)(p11.2;q11.2), absent in both parents' karyotype analysis.
X-inactivation studies performed on fibroblast cells of the proband revealed that she has an extremely skewed X-inactivation (100%) with preferencial use of the translocated X chromosome, as is usually observed in balanced X;autosome translocations (15) .
FISH mapping of the chromosome Xp11.22 breakpoint. In order to map the translocation breakpoints, we initially used the karyotype information and the available physical maps to establish genomic contigs in the regions of interest. FISH experiments were performed with a set of YAC and BAC clones selected in the contigs and spanning the Xp11.2 and 20q11.2 genomic regions (data not shown). FISH studies allowed the identification of two BAC clones, RP11-957H19 and RP11-473J14, spanning, respectively, the translocation breakpoints of the 20q11.22 and Xp11.22 regions (Fig. 1) .
BAC RP11-957H19 covers a segment of 181 kb on the 20q11.22 region and contains 3 known transcripts: a gene called ASIP, encoding a paracrine signaling molecule, the AHCY gene, coding for an S-adenosylhomocysteine hydrolase and the ITCH gene, encoding an E3 ubiquitin protein ligase.
BAC RP11-473J14 spans 11.2 kb in Xp11.22, inside the first intron (28.5 kb) of the IQSEC2 transcript (acc. AB011094) that spans ≥88.5 kb (Fig. 2) . The genomic clone RP11-473J14 has been entirely sequenced. Bioinformatic analysis of its genomic sequence revealed that IQSEC2 is the only transcript contained within this clone. Among the genomic clones used in this study, RP11-473J14 in particular is specific for the longest isoform (see below), which is presumably interrupted by the translocation in this patient. The IQSEC2 protein is characterized by the presence of a domain known to function as a guanine nucleotide exchange factor, by an IQ calmodulinbinding region motif and by a pleckstrin homology (16, 17) .
Three different isoforms have been reported in both human and mouse for this transcript (AB011094, AK095232 and BE883792) (17) (Fig. 2) . The three alternative splice forms belong to the UniGene cluster Hs.496138. The longer isoform (AB011094), which is presumably interrupted, is only represented by mRNA from the brain, although the possible involvement of all three isoforms cannot be ruled out. Further experiments are needed to clarify this issue. The third splice variant, acc. BE883792, represents a shorter isoform of the transcript and encodes a 183-aminoacid protein.
Expression studies of Iqsec2. In order to obtain information on the expression pattern of the IQSEC2 gene, we performed expression analysis of the murine homolog Iqsec2 by RNA in situ hybridization (ISH) on murine embryo tissue sections from E14.5 and E16.5, and adult brain. Experiments were performed using two different probes, a first RNA probe that hybridizes to exons 4-5 and corresponds to human BE883792 (murine cDNA clone IMAGE:803296) and a second probe that hybridizes to the 3'UTR and corresponds to the human isoforms AB011094 and AK095232 (murine cDNA clone IMAGE:6530479). ISH experiments performed on the serial sagittal sections of embryonic day 14.5 embryos show a clear signal restricted to the central and peripheral nervous systems, as shown in Fig. 3 . The same results were obtained with the two different riboprobes described above. the neopallial cortex, midbrain, cerebellum, medulla oblongata, spinal cord and dorsal root ganglia (Fig. 3a-c ). Significant and specific expression was also detected in the pituitary primordium and trigeminal ganglion (data not shown).
In situ hybridization analysis of postnatal mouse brain (week 8) revealed expression of the Iqsec2 gene in the hippocampal formation comprising hippocampus proper and dental gyrus, in the olfactory bulb, the cerebral cortex and the cerebellum (Fig. 3d) .
Mutation analysis. In order to exclude the possible involvement of ARX, MECP2 and CDKL5, mutation analysis for these transcripts was performed on patient AD as described (8, 14) ( Table I ). This analysis revealed the absence of pathogenic mutations.
The observation that the IQSEC2 gene is interrupted in AD and is highly expressed in the central and peripheral nervous systems makes it a good candidate for neurological disorders. To further assess the role of the IQSEC2 gene in ISS and Xlinked Rett-like phenotype with early-onset seizures, we screened a cohort of 40 unrelated female patients available at the RTT Italian biobank (www.biobank.unisi.it). These included 11 classic RTT patients, 20 atypical RTT patients (6 with early-onset seizures) and 9 RTT-like patients. All had already been screened for mutations in MECP2 and CDKL5. Mutation analysis was performed on coding exons and splice junctions for all isoforms of the IQSEC2 gene and on the genomic DNA of the probands. No causative mutations were identified.
Discussion
Although hypsarrhythmia, West Syndrome and ISS are not the same, they are used interchangeably because one almost always accompanies the other. The incidence of this type of epilepsy is about 1:2-4000 children. It usually occurs in the first months of age and is characterized by seizures, mental retardation and chaotic brain activity on the EEG (hypsarrhythmia), and is accompanied by developmental arrest or regression. In most cases, the etiology is unknown.
We report on a female patient (AD) with a balanced de novo X;autosome translocation [46,X,t(X;20)(p11.2;q11.2)] who showed developmental regression that started at the age of 6 months and the early onset of infantile spasms at around 15 months of age, refractory to medical treatment. Chromosome breakpoints in the patient were defined and precisely assigned to the corresponding genomic regions of chromosome X and 20, and further research identified a transcript on the short arm of the X chromosome, interrupted by the translocation breakpoint. Only one of the three IQSEC2 variants (acc. AB011094) seems to be truncated by the rearrangement and, intriguingly, this variant is represented by a cDNA clone from brain. One hypothesis is that this isoform is preferentially expressed in the human brain and that its disruption is linked to the patient's phenotype, or that the impairment of all three variants is involved in the phenotype observed in patient AD. A functional copy of the gene is present in the patient, due to the reported IQSEC2 escape of X inactivation in humans (17) , and in order to assess whether one or more isoforms are missing, expression studies of the different splice variants should be conducted. We postulate that the severity of the phenotype could be caused by the absolute requirement of at least two functional copies of the gene within each cell in affected tissues, such as the central nervous system; the retained half dosage of the functional gene could be insufficient for the normal life of cells.
The clinical manifestations observed in our patient share similarities with two other X-linked conditions known to be associated with infantile spasms, ISS and Rett-like syndrome with early-onset seizures, caused by mutations in the ARX and CDKL5 genes. To date, mutations in ARX and CDKL5 account for a small percentage of cases. Several pieces of evidence suggest the existence of additional loci, which may be associated with this group of disorders (3) .
As has been shown in other genetic diseases, the characterization of chromosomal rearrangements may be a powerful tool for the identification of genes responsible for genetic disorders. These considerations prompted us to hypothesize that IQSEC2 could represent a possible candidate gene for the above-mentioned disorder.
IQSEC2 codes for a guanine nucleotide-exchange protein (GEP) and has two paralogs (IQSEC1 and IQSEC3). These proteins activate ADP-ribosylation factors (ARFs), which are guanine nucleotide binding proteins belonging to the Ras superfamily of GTPases that modulate the formation of vesicles during intracellular protein trafficking, and are called ARF-GEPs (16) . IQSEC2 and the other ARF-GEPs are involved in the activation of ARFs through the acceleration of the replacement of bound GDP with GTP. These proteins are characterized by the presence of a Sec7 domain, first found in yeast, which may be responsible for their guanine-nucleotide exchange activity. IQSEC2 also contains a pleckstrin homology (PH) domain commonly found in eucaryotic signalling proteins and required for phosphoinositide binding. Several genes involved in Ras-homologous GTPase, such as OPHN1, ARHGEF6, GDI1 and PAK3, have been proven responsible for different forms of X-linked mental retardation (18) . ARHGEF6 in particular, which is similar to IQSEC2, codes for a protein with guanine-nucleotide exchange activity.
RNA in situ hybridization studies revealed that Iqsec2 is highly expressed during development in the central and peripheral nervous systems. A comparison of the expression patterns of Iqsec2 and Cdkl5 in murine adult brain showed a significant overlap of the two signals, as they are both expressed in the basal ganglia, olfactory bulb, cerebral cortex, cerebellum and hippocampus (9) . This indicates that Cdkl5 and Iqsec2 expression may coexist in the same cells, suggesting a possible functional link between the two proteins. This, however, remains to be proved.
These data lead us to hypothesise that the phenotype observed in AD could be due to the interruption of the IQSEC2 transcript. It should be noted that a familial case, showing a balanced translocation t(X;22)(p11.22;p11) and displaying an RTT phenotype with early-onset seizures, has previously been described (19) . Unfortunately, this patient has not been fully characterized and we do not know whether the breakpoint is identical to that of AD. Nevertheless, these data indicate the involvement of the Xp11.22 region at the location of IQSEC2, and suggest the possible involvement of the transcript in the pathogenesis of this neurological phenotype.
Mutation analysis performed on a representative subset of patients did not reveal mutations. However this, for several reasons, does not exclude the possible involvement of IQSEC2. Additional testing on a larger cohort of patients, in particular male patients with infantile spasms who are negative for ARX mutation analysis, is necessary before any conclusions can be drawn.
We cannot rule out the possibility that the phenotype observed in our patient is not caused by the interruption of IQSEC2 but is due, rather, to the haploinsufficiency of one of the three genes located in the genomic clones spanning the breakpoint on chromosome 20. These genes include the ASIP gene, which encodes a molecule involved in melanin biogenesis, the AHCY gene, which codes for a S-adenosylhomocysteine hydrolase, and the ITCH gene, encoding an E3 ubiquitin protein ligase. Previous studies have shown that mutations in the ubiquitin protein ligase E3A (UBE3A) gene cause Angelman syndrome (20, 21) , which partially overlaps with the clinical manifestations observed in our patient. In addition, Mecp2 deficiency has been shown to cause reduced expression of Ube3a in the brain of Mecp2 knockout mice (22) . Recently, Nascimento et al reported that a mutation of the UBE2A gene, which encodes a ubiquitin-conjugating enzyme (E2), is the cause of a novel X-linked mental retardation syndrome (23) . Further studies are needed to understand the possible relationship between the ITCH gene and the phenotype observed in patient AD.
To understand the role of genes on chromosome 20, further studies, such as the characterization of the breakpoint from a molecular point of view or expression studies on mRNA to investigate the presence of double copies of each gene, will be needed. Moreover, we cannot rule out the possibility of a position effect causing an alteration of expression in genes in the vicinity of the breakpoint; an example is the JARID1C gene (acc. NM_004187), which lies only 7 kb from 3' of IQSEC2. Mutations in this transcript have been associated with X-linked mental retardation (24) , so an alteration of JARID1C gene expression could be involved in patient phenotype. Lastly, the possibility of a fusion transcript and the consequent possible dominant effect should be considered for further studies.
In conclusion, we believe that the data reported here could make the IQSEC2 transcript a candidate gene for X-linked neurological disorders, although further studies on different cohorts of patients will be needed to validate this hypothesis.
